Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Autor:
Stephen M. Ansell, Svetomir N. Markovic, Luis F. Porrata, Ivana N. Micallef, William J. Hogan, David J. Inwards, Patrick B. Johnston
Publikováno v:
Journal of Hematology & Oncology
Background The infused autograft lymphocyte-to-monocyte ratio (A-LMR) is a prognostic factor for survival in B-cell lymphomas post-autologous peripheral hematopoietic stem cell transplantation (APHSCT). Thus, we set out to investigate if the A-LMR is
Autor:
Yong-Mei Zhu, Jing Wu, Chun-Lei Jiang, Shu-Min Xiong, Xiaodong Xi, Yan Sheng, Bing Chen, Qing-lei Kong, Yunxiang Zhang, Junmin Li, Qi Cao, Sai-Juan Chen, Cong Yu, Xiang-Qin Weng
Publikováno v:
Journal of Hematology & Oncology
Background Minimal residual disease detection in the bone marrow is usually performed in patients with acute myeloid leukemia undergoing one course of induction chemotherapy. To optimize the chemotherapy strategies, more practical and sensitive marke
Autor:
Wen-Zhao Zhong, Ri-Qiang Liao, Hong-Hong Yan, Zhi-Hong Chen, Hai-Yan Tu, Song Dong, Yi-Long Wu, Qiang Nie, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Xue-Ning Yang, Jian Su
Publikováno v:
Journal of Hematology & Oncology
Background Neoadjuvant erlotinib and customized adjuvant therapy are appealing but controversial. The purpose of this study was to evaluate the role of biomarker-guided neoadjuvant treatment strategy in patients with IIIA-N2 non-small cell lung cance
Autor:
Yi Su, Zhong Yuan, Sanbin Wang, Lei Gao, Bin Li, Tonghua Yang, Yao Liu, Cheng Zhang, Xi Zhang, Li Gao
Publikováno v:
Journal of Hematology & Oncology
Background Since the introduction of tyrosine kinase inhibitors (TKIs) into combination chemotherapy regimens, the majority of newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients have achieved complete rem
Autor:
Yao Wang, Jianhua Huang, Yelei Guo, Yang Liu, Qingming Yang, Kaichao Feng, Haiyan Lv, Hanren Dai, Weidong Han
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2017)
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2017)
Background Cholangiocarcinoma (CCA) is one of the most fatal malignant tumors with increasing incidence, mortality, and insensitivity to traditional chemo-radiotherapy and targeted therapy. Chimeric antigen receptor-modified T cell (CART) immunothera
Autor:
Vivek Subbiah, Ann Marie Bailey, Gordon B. Mills, Lance C. Pagliaro, John F. Ward, Funda Meric-Bernstam, Kenna R. Mills Shaw, Priya Rao
Publikováno v:
Journal of Hematology & Oncology
Background Germ cell tumors (GCT) are the most common solid tumors in adolescent and young adult males (age 15 and 35 years) and remain one of the most curable of all solid malignancies. However a subset of patients will have tumors that are refracto
Autor:
Jianmin Wang, Xin Wang, Xi Zhang, Linghui Xia, Qifa Liu, Depei Wu, Xiao-Jun Huang, Song Jin, Sujun Gao, Hai Bai, Shunqing Wang, Ming Jiang, Lan-Ping Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refractory to immunosuppressive ther
Autor:
Jae Sook Ahn, Eunkyung Park, Yong Park, Jin Seok Kim, Suee Lee, Cheolwon Suh, Young Rok Do, Hyeon-Seok Eom, Dok Hyunyoon, Joung Soon Jang, Yoo Hong Min, Hwe Won Lee, Yu Ri Kim, Seok Jin Kim, Jae Heon Jeong, Yeung-Chul Mun, Ho Jin Shin, Seong Hyun Jeong, Joon Seong Park, Won Sik Lee, Sung Yong Oh, Won Seog Kim, Sun Kyung Baek
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 5, Iss 1, p 49 (2012)
Journal of Hematology & Oncology, Vol 5, Iss 1, p 49 (2012)
Background The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland. Methods Thirty one patients diagnosed with primary adrenal DLBCL from 14 Korea
Autor:
Joseph McGuirk, Gang Hao, Casey Williams, Sunil Abhyankar, Jianda Yuan, Robert Belt, Ying Yan, Xiuqin Guan, Shaun DeJarnette, Jeffery Wieman, Weijian Hou, Weisi Yan
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 2, Iss 1, p 17 (2009)
Journal of Hematology & Oncology, Vol 2, Iss 1, p 17 (2009)
We studied serum proteomic profiling in patients with graft versus host disease (GVHD) after allogeneic hematopoietic cell transplantation (allo-HCT) by two-dimensional gel electrophoresis (2-DE) and mass spectrometry analysis. The expression of a gr
Autor:
Thomas Chang, Saloomeh Vahdat, Pedro DeBrito, Constanza J Gutierrez, Giuseppe Esposito, Filip Banovac, Sean P. Collins, Eric D. Anderson, Eric K. Oermann, Brian T. Collins, Simeng Suy, Xia Yu, Shadi Yousefi, Malak Abedalthagafi
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 3, Iss 1, p 6 (2010)
Journal of Hematology & Oncology, Vol 3, Iss 1, p 6 (2010)
Objective To report serial 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) tumor response following CyberKnife radiosurgery for stage IA non-small cell lung cancer (NSCLC). Methods Patients with biopsy-pro